183 related articles for article (PubMed ID: 33452454)
1. ANO1 regulates the maintenance of stemness in glioblastoma stem cells by stabilizing EGFRvIII.
Kim HJ; Kim JY; Jung CW; Lee YS; An JY; Kim EH; Kim KH; Lee SP; Park JY; Park MJ
Oncogene; 2021 Feb; 40(8):1490-1502. PubMed ID: 33452454
[TBL] [Abstract][Full Text] [Related]
2. Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs).
Li X; Tao Z; Wang H; Deng Z; Zhou Y; Du Z
Exp Cell Res; 2020 Nov; 396(1):112261. PubMed ID: 32896567
[TBL] [Abstract][Full Text] [Related]
3. PARK7 maintains the stemness of glioblastoma stem cells by stabilizing epidermal growth factor receptor variant III.
Kim JY; Kim HJ; Jung CW; Choi BI; Lee DH; Park MJ
Oncogene; 2021 Jan; 40(3):508-521. PubMed ID: 33188296
[TBL] [Abstract][Full Text] [Related]
4. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3.
Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ
Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038
[TBL] [Abstract][Full Text] [Related]
5. Semaphorin 3A mediated brain tumor stem cell proliferation and invasion in EGFRviii mutant gliomas.
Higgins DMO; Caliva M; Schroeder M; Carlson B; Upadhyayula PS; Milligan BD; Cheshier SH; Weissman IL; Sarkaria JN; Meyer FB; Henley JR
BMC Cancer; 2020 Dec; 20(1):1213. PubMed ID: 33302912
[TBL] [Abstract][Full Text] [Related]
6. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
[TBL] [Abstract][Full Text] [Related]
7. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in Glioblastoma.
Soroceanu L; Matlaf L; Khan S; Akhavan A; Singer E; Bezrookove V; Decker S; Ghanny S; Hadaczek P; Bengtsson H; Ohlfest J; Luciani-Torres MG; Harkins L; Perry A; Guo H; Soteropoulos P; Cobbs CS
Cancer Res; 2015 Aug; 75(15):3065-76. PubMed ID: 26239477
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122.
Su R; Cao S; Ma J; Liu Y; Liu X; Zheng J; Chen J; Liu L; Cai H; Li Z; Zhao L; He Q; Xue Y
Mol Cancer; 2017 Nov; 16(1):171. PubMed ID: 29132362
[TBL] [Abstract][Full Text] [Related]
10. EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties.
Miao H; Gale NW; Guo H; Qian J; Petty A; Kaspar J; Murphy AJ; Valenzuela DM; Yancopoulos G; Hambardzumyan D; Lathia JD; Rich JN; Lee J; Wang B
Oncogene; 2015 Jan; 34(5):558-67. PubMed ID: 24488013
[TBL] [Abstract][Full Text] [Related]
11. Suppression of CaMKIIβ Inhibits ANO1-Mediated Glioblastoma Progression.
Sim KM; Lee YS; Kim HJ; Cho CH; Yi GS; Park MJ; Hwang EM; Park JY
Cells; 2020 Apr; 9(5):. PubMed ID: 32357567
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant glioma.
Katanasaka Y; Kodera Y; Kitamura Y; Morimoto T; Tamura T; Koizumi F
Mol Cancer; 2013 Apr; 12():31. PubMed ID: 23617883
[TBL] [Abstract][Full Text] [Related]
13. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
14. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
Sareddy GR; Pratap UP; Venkata PP; Zhou M; Alejo S; Viswanadhapalli S; Tekmal RR; Brenner AJ; Vadlamudi RK
Stem Cells; 2021 May; 39(5):536-550. PubMed ID: 33470499
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C
Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687
[TBL] [Abstract][Full Text] [Related]
16. Saccharina japonica Extract Suppresses Stemness of Glioma Stem Cells by Degrading Epidermal Growth Factor Receptor/Epidermal Growth Factor Receptor Variant III.
Kim SY; Kim JY; Shin WS; Lee SJ; Chi SG; Lee JY; Park MJ
J Med Food; 2018 May; 21(5):496-505. PubMed ID: 29648968
[TBL] [Abstract][Full Text] [Related]
17. Morusin inhibits glioblastoma stem cell growth in vitro and in vivo through stemness attenuation, adipocyte transdifferentiation, and apoptosis induction.
Guo H; Liu C; Yang L; Dong L; Wang L; Wang Q; Li H; Zhang J; Lin P; Wang X
Mol Carcinog; 2016 Jan; 55(1):77-89. PubMed ID: 25557841
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of glioblastoma multiforme stem-like cells leads to downregulation of EGFR and EGFRvIII and decreased tumorigenic and stem-like cell potential.
Stockhausen MT; Kristoffersen K; Stobbe L; Poulsen HS
Cancer Biol Ther; 2014 Feb; 15(2):216-24. PubMed ID: 24525857
[TBL] [Abstract][Full Text] [Related]
19. TRIM24 promotes stemness and invasiveness of glioblastoma cells via activating Sox2 expression.
Zhang LH; Yin YH; Chen HZ; Feng SY; Liu JL; Chen L; Fu WL; Sun GC; Yu XG; Xu DG
Neuro Oncol; 2020 Dec; 22(12):1797-1808. PubMed ID: 32492707
[TBL] [Abstract][Full Text] [Related]
20. The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets.
Cenciarelli C; Marei HE; Zonfrillo M; Casalbore P; Felsani A; Giannetti S; Trevisi G; Althani A; Mangiola A
Oncotarget; 2017 Mar; 8(11):17873-17886. PubMed ID: 28157712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]